Ophthalmic Dispensers Recommended Class I Designation By FDA Panel
…and the first tangible impacts of the Genus vs. FDA decision
The FDA’s Ophthalmic Devices Panel approved a Class I designation for ophthalmic dispensers, which were reclassified from drugs to devices after the Genus v. FDA decision.
You may also be interested in...
The FDA sent a warning letter to Arbor Center for EyeCare for failing to submit an IND before beginning a trial of a novel drug-device combination product.
The General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee will meet from 26-27 October, and the Ophthalmic Devices Panel of the Medical Devices Advisory Committee will meet 10 November.
After losing the recent Genus Medical Technologies court case, the US FDA will begin transitioning certain imaging agent drugs to devices. Because user-fee deadlines for drugs and generics are approaching, the agency says firms should pay those fees now and ask for a refund after the transition.